Obstetric Cholestasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention: Drug: LUM001Sponsor: ShireRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention: Drug: LUM001Sponsors: Lumena Pharmaceuticals, Inc.; Childhood Liver Disease Research and Education NetworkRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)Intervention: Drug: LUM001Sponsor: ShireRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2014 Category: Research Source Type: clinical trials
The Metabolic Profile of Obstetric Cholestasis
Condition: Cholestasis of PregnancyIntervention: Sponsor: Imperial College LondonRecruiting - verified September 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2011 Category: Research Source Type: clinical trials